Clinical Scorecard: A Predictive Nomogram for Assessing Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma
At a Glance
Category
Detail
Condition
Papillary Thyroid Carcinoma
Key Mechanisms
Lymph node metastasis as the predominant metastatic pathway, influenced by clinicopathological variables, hematological biomarkers, and psychological status.
Target Population
Patients with papillary thyroid carcinoma, particularly middle-aged and older women.
Care Setting
Department of Thyroid and Neck Oncology at Tianjin Medical University Cancer Hospital.
Key Highlights
Developed a nomogram for predicting lymph node metastasis in papillary thyroid carcinoma.
Incorporated routine hematological biomarkers (PLT and APTT) and psychological assessment (PHQ-9).
Achieved AUC indices of 0.8045 for training set and 0.8146 for verification set.
Guideline-Based Recommendations
Diagnosis
Utilize a nomogram integrating clinicopathological variables, hematological biomarkers, and psychological assessment for preoperative risk stratification.
Management
Surgical intervention and prophylactic cervical lymph node dissection are standard treatments.
Monitoring & Follow-up
Assess emotional distress using PHQ-9 as part of preoperative evaluation.
Risks
Inadequate treatment may lead to tumor recurrence; excessive treatment may affect quality of life.
Patient & Prescribing Data
Patients with papillary thyroid carcinoma undergoing preoperative assessment.
Incorporating psychological factors and hematological parameters may enhance predictive accuracy for lymph node metastasis.
Clinical Best Practices
Employ a comprehensive nomogram for assessing lymph node metastasis risk.
Consider psychological status in preoperative evaluations.
